Subsequent studies have shown that the cGAS-STING signaling pathway is an important contributor to antitumor immunity after radiotherapy by detecting DNA damage in tumor cells and promoting the recognition of tumor-derived DNA in immune cells (158, 159). Here, STING1 is linked to neoplasm.